GlucoBalance (Gaby & Wright Formula) 90C

Price in points: 64 points
309 item(s)
1855

$64.00

Type I & II Diabetes, elevated triglycerides, LDL cholesterol, decreased HDL cholesterol, dysinsulinism, and Syndrome X glucose 

+

NPN: 80041543

Item Code: 1855

Quantity: 90 capsules

 

 

 

 

 

Description: Glycemic Formula­, Adrenal Support.

Indications: Formulated for Biotics Research by Jonathan V. Wright, M.D. and Alan R. Gaby, M.D., leaders in the field of nutritional science. Consider hypo-hyperglycemia (Type I & II Diabetes), elevated triglycerides and LDL cholesterol, decreased HDL cholesterol, dysinsulinism, and Syndrome X; consider with ADHS™ and Flax Seed Oil

Ingredients: See Product Label below.

Suggestion: 2-3 capsules two times daily with meals or as directed.

Safety: Note: Insulin-dependent diabetics must monitor their blood sugar levels frequently, since this product will often dramatically reduce blood glucose

References: Additional references:

A scientific review: the role of chromium in insulin resistance. Diabetes Educ. 2004;Suppl:2-14.

Cheng HH, Lai MH, Hou WC, Huang CL.J Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects. J Agric Food Chem. 2004 Mar 10;52( 5):1385-9

Fox CH, Ramsoomair D, Mahoney MC, Carter C, Young B, Graham R. An investigation of hypomagnesemia among ambulatory urban African Americans. J Fam Pract. 1999 Aug;48( 8):636-9

Shamberger RJ. Calcium, magnesium, and other elements in the red blood cells and hair of normals and patients with premenstrual syndrome. Biol Trace Elem Res. 2003 Aug;94( 2):123-9

Iketani T, Kiriike N, Murray, Stein B, Nagao K, Nagata T, Minamikawa N, Shidao A, Fukuhara H. Effect of menatetrenone ( vitamin K2) treatment on bone loss in patients with anorexia nervosa. Psychiatry Res. 2003 Mar 25;117( 3):259-69

McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med. 2004 May 13;350( 20):2042-9

Eisinger J, Clairet D. Effects of silicon, fluoride, etidronate and magnesium on bone mineral density: a retrospective study. Magnes Res. 1993 Sep;6( 3):247-9

Schiano A, Eisinger F, Detolle P, Laponche AM, Brisou B, Eisinger J. [Silicon, bone tissue and immunity] [Article in French] Rev Rhum Mal Osteoartic. 1979 Jul-Sep;46( 7-9):483-6

Schaafsma A, de Vries PJ, Saris WH. Delay of natural bone loss by higher intakes of specific minerals and vitamins. Crit Rev Food Sci Nutr. 2001 May;41( 4):225-49

Volpe SL, Taper LJ, Meacham S. The relationship between boron and magnesium status and bone mineral density in the human: a review. Magnes Res. 1993 Sep;6( 3):291-6

Nielsen FH. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones. Magnes Trace Elem. 1990;9( 2):61-9

Fletcher RH, Fairfield KM. Vitamins for chronic disease prevention in adults: clinical applications. JAMA. 2002 Jun 19; 287( 23): 3127-9

Ames BN, Elson-Schwab I, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity ( increased K( m)): relevance to genetic disease and polymorphisms. Am J Clin Nutr. 2002 Apr;75( 4):616-58

Product Label (GlucoBalance_1855_90_NEW.png, 539 Kb) [Download]

PDF Attachment (LIT-050_GlucoBalance_trifold_2019-CAN_REVISED__1_.pdf, 695 Kb) [Download]

LIT-011 GlucoBalance 2019-CAN REVISED (LIT-011_GlucoBalance_2019-CAN__2__REVISED.pdf, 522 Kb) [Download]

PDF Document (LIT-245_-CardioCAN-Print.pdf, 4,327 Kb) [Download]